Pinned post
We will be here: @malmberglab.bsky.social
MalmbergLab
@MalmbergLab
The Malmberg Lab studies the functional regulation of natural killer (NK) cells and seeks to employ new insights in NK cell biology in cancer immunotherapy
1.4K Following 2.4K Followers 1K Posts
Latest posts 5
Great work, congrats. This is where we have to go.
Please check out our paper published in @NatureMedicine on our Phase I trial of AFM13-precomplexed cord blood NK cells in relapsed/refractory CD30+ lymphomas. Led by Dr. Yago Nieto and an outstanding team of coauthors and collaborators, this study marks the first clinical demonstration of NK cell redirection using a bispecific engager. We report an ORR of 92.9% and CR of 66.7% in 42 patients with a median of 7 prior therapies and show that this approach is safe and may serve as a bridge to SCT. Excited to move forward with our next generation engineered NK cells in combination with engagers and mAbs. #CancerResearch #Immunotherapy #NKcells @MDAndersonNewsView quoted post on X
Incredibly impressing ongoing work in the UK NK community. Thanks for the invitation @mjwsim. Looking forward to discussing more NK and KIR work in the coming days and to the yearly double 馃幘 with @DrFran_Colucci
Wow. What an amazing day. So great to see so much great science about my favourite immune cells. Thanks to everyone who came and especially @MalmbergLab for a stellar keynote.View quoted post on X
Wow, congrats @PN0rmski. Beautiful work!
A cell intrinsic NKG2A/C switch receptor to overcome the critical HLA-E checkpoint. Fun collaboration with the Michel Sadelain lab. Michelle S忙tersmoen, Ivan Kotchetkov, @LambertoTR @CoE_PRIMA @UniOslo_MED @Oslounivsykehus @CIM_Sweden
Online Now: Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor dlvr.it/TFV5VCView quoted post on X
